Literature DB >> 10912197

Experience with neurocysticercosis in the UK: correct diagnosis and neurosurgical management of the small enhancing brain lesion.

J P Wadley1, R A Shakir, J M Rice Edwards.   

Abstract

Neurocysticercosis is a major cause of epilepsy and other neurological morbidity in endemic areas of the world but is exceptionally rare in the West. We have recently had experience of eight patients with this condition, seven presenting with epilepsy and single or multiple small, enhancing parenchymal lesions and one with hydrocephalus caused by a midbrain lesion. One lesion was stereotactically excised after it persisted, but in five other cases spontaneous cyst resolution was observed during expectant management with anticonvulsants. Two patients with multiple lesions were referred to us for further management but were free of active infection. Recent studies show that neurocysticercosis may often be diagnosed based upon the clinical, epidemiological and radiological features. Spontaneous cyst resolution is to be expected in this condition and suspected patients should be carefully observed and surgery avoided. We believe that this disease presents more commonly than has been appreciated in the UK and propose a protocol for management.

Entities:  

Mesh:

Year:  2000        PMID: 10912197     DOI: 10.1080/026886900408388

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  3 in total

Review 1.  Cysticerci-related single parenchymal brain enhancing lesions in non-endemic countries.

Authors:  Oscar H Del Brutto; Theodore E Nash; Hector H Garcia
Journal:  J Neurol Sci       Date:  2012-05-31       Impact factor: 3.181

2.  Claude's syndrome associated with neurocysticercosis.

Authors:  Tae-Jin Song; Sang Hyun Suh; Hanna Cho; Kyung-Yul Lee
Journal:  Yonsei Med J       Date:  2010-11       Impact factor: 2.759

Review 3.  Epidemiology and management of cysticercosis and Taenia solium taeniasis in Europe, systematic review 1990-2011.

Authors:  Lorenzo Zammarchi; Marianne Strohmeyer; Filippo Bartalesi; Elisa Bruno; José Muñoz; Dora Buonfrate; Alessandra Nicoletti; Héctor Hugo García; Edoardo Pozio; Alessandro Bartoloni
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.